1-Hydroxypyrene multiple interactions ISO RGD:734008 6480464 [Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in increased expression of FST protein CTD PMID:31228248 1-naphthyl isothiocyanate increases expression ISO RGD:2633 6480464 1-Naphthylisothiocyanate results in increased expression of FST mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression ISO RGD:2633 6480464 Ethinyl Estradiol results in decreased expression of FST mRNA CTD PMID:12655037 more ... 17alpha-ethynylestradiol affects expression ISO RGD:2633 6480464 Ethinyl Estradiol affects the expression of FST mRNA CTD PMID:16551644 , PMID:26865667 17beta-estradiol affects expression ISO RGD:734008 6480464 Estradiol affects the expression of FST mRNA CTD PMID:14699072 17beta-estradiol affects expression ISO RGD:2633 6480464 Estradiol affects the expression of FST mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA CTD PMID:32186404 17beta-estradiol increases expression ISO RGD:734008 6480464 Estradiol results in increased expression of FST mRNA CTD PMID:31646340 17beta-estradiol multiple interactions ISO RGD:734008 6480464 Estradiol inhibits the reaction [Fulvestrant results in increased expression of FST mRNA], Fulvestrant inhibits the reaction [Estradiol results in increased expression of FST mRNA] CTD PMID:31646340 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FST mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FST mRNA, Estradiol results in decreased expression of FST mRNA alternative form CTD PMID:22285243 , PMID:23144751 17beta-estradiol decreases expression ISO RGD:734008 6480464 Estradiol results in decreased expression of FST mRNA CTD PMID:16298037 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of FST mRNA CTD PMID:17023530 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734008 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FST mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2633 6480464 Tetrachlorodibenzodioxin affects the expression of FST mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FST mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2633 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FST mRNA] more ... CTD PMID:23196670 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2633 6480464 Tetrachlorodibenzodioxin results in increased expression of FST mRNA CTD PMID:23196670 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FST mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:734008 6480464 Tetrachlorodibenzodioxin results in decreased expression of FST mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FST mRNA CTD PMID:17586704 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734008 6480464 Tetrachlorodibenzodioxin results in increased expression of FST mRNA, Tetrachlorodibenzodioxin results in increased expression of FST protein CTD PMID:11007951 , PMID:16083274 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2633 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid increases expression ISO RGD:734008 6480464 Lactic Acid results in increased expression of FST mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2633 6480464 3 more ... CTD PMID:23196670 3-Hydroxybenzo[a]pyrene multiple interactions ISO RGD:734008 6480464 [Polycyclic Aromatic Hydrocarbons results in increased abundance of 3-hydroxybenzo(a)pyrene] which results in increased expression of FST protein CTD PMID:31228248 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:734008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FST mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FST mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of FST mRNA CTD PMID:20713471 3-Nitrobenzanthrone increases expression ISO RGD:734008 6480464 3-nitrobenzanthrone results in increased expression of FST mRNA CTD PMID:34036453 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of FST mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression ISO RGD:2633 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FST mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of FST mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:734008 6480464 Decitabine results in increased expression of FST mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of FST mRNA CTD PMID:27915011 6-propyl-2-thiouracil decreases expression ISO RGD:2633 6480464 Propylthiouracil results in decreased expression of FST mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:2633 6480464 acetamide results in increased expression of FST mRNA CTD PMID:31881176 acetylsalicylic acid affects expression ISO RGD:2633 6480464 Aspirin affects the expression of FST mRNA CTD PMID:12800193 aflatoxin B1 increases expression ISO RGD:734008 6480464 Aflatoxin B1 results in increased expression of FST mRNA CTD PMID:21641981 , PMID:32234424 aflatoxin B1 decreases methylation ISO RGD:734008 6480464 Aflatoxin B1 results in decreased methylation of FST gene CTD PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of FST mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of FST mRNA more ... CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:734008 6480464 Tretinoin results in decreased expression of FST mRNA CTD PMID:21934132 ammonium chloride affects expression ISO RGD:2633 6480464 Ammonium Chloride affects the expression of FST mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:734008 6480464 Antirheumatic Agents results in increased expression of FST mRNA CTD PMID:24449571 Archazolid B decreases expression ISO RGD:734008 6480464 archazolid B results in decreased expression of FST mRNA CTD PMID:25218289 arsenite(3-) multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of FST mRNA CTD PMID:15894712 arsenite(3-) increases expression ISO RGD:734008 6480464 arsenite results in increased expression of FST mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:734008 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of FST mRNA], Fulvestrant inhibits the reaction [arsenite results in increased expression of FST mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO RGD:734008 6480464 arsenite results in decreased expression of FST mRNA CTD PMID:23974009 arsenite(3-) increases methylation ISO RGD:734008 6480464 arsenite results in increased methylation of FST promoter CTD PMID:23974009 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of FST mRNA CTD PMID:15894712 arsenous acid multiple interactions ISO RGD:734008 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FST protein] CTD PMID:26598702 atrazine multiple interactions ISO RGD:734008 6480464 [Atrazine co-treated with Arsenates] results in increased expression of FST mRNA CTD PMID:18585445 atrazine decreases expression ISO RGD:2633 6480464 Atrazine results in decreased expression of FST mRNA CTD PMID:36841081 azathioprine increases expression ISO RGD:734008 6480464 Azathioprine results in increased expression of FST mRNA CTD PMID:22623647 benzo[a]pyrene multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of FST mRNA CTD PMID:15894712 benzo[a]pyrene increases expression ISO RGD:734008 6480464 Benzo(a)pyrene results in increased expression of FST mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:734008 6480464 Benzo(a)pyrene results in decreased expression of FST mRNA CTD PMID:22178795 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of FST mRNA CTD PMID:15894712 more ... benzo[a]pyrene decreases expression ISO RGD:2633 6480464 Benzo(a)pyrene results in decreased expression of FST mRNA CTD PMID:21839799 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of FST mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I increases expression ISO RGD:734008 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of FST mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of FST mRNA CTD PMID:15674843 bis(2-chloroethyl) sulfide decreases expression ISO RGD:734008 6480464 Mustard Gas results in decreased expression of FST mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of FST protein CTD PMID:27495896 bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of FST mRNA CTD PMID:27495896 bisphenol A affects expression ISO RGD:734008 6480464 bisphenol A affects the expression of FST mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of FST mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:734008 6480464 bisphenol A results in decreased expression of FST mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:734008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FST mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:2633 6480464 bisphenol A results in decreased expression of FST mRNA CTD PMID:25181051 , PMID:32145629 bisphenol F multiple interactions ISO RGD:734008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FST mRNA CTD PMID:28628672 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of FST mRNA CTD PMID:36706583 bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of FST mRNA CTD PMID:30951980 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of FST mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:734008 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FST mRNA CTD PMID:29432896 butyric acid decreases expression ISO RGD:2633 6480464 Butyric Acid results in decreased expression of FST mRNA CTD PMID:12800193 cadmium atom decreases expression ISO RGD:734008 6480464 Cadmium results in decreased expression of FST mRNA CTD PMID:24376830 cadmium atom increases expression ISO RGD:734008 6480464 Cadmium results in increased expression of FST mRNA CTD PMID:31646340 cadmium dichloride increases methylation ISO RGD:2633 6480464 Cadmium Chloride results in increased methylation of FST promoter CTD PMID:22457795 calciol increases expression EXP 6480464 Cholecalciferol results in increased expression of FST mRNA CTD PMID:17170073 calcitriol multiple interactions ISO RGD:734008 6480464 FST protein inhibits the reaction [Calcitriol results in decreased expression of CLEC3B mRNA] more ... CTD PMID:23589129 calcitriol decreases expression ISO RGD:734008 6480464 Calcitriol results in decreased expression of FST protein CTD PMID:23589129 carbon nanotube increases expression ISO RGD:734008 6480464 Nanotubes, Carbon results in increased expression of FST mRNA CTD PMID:24389112 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of FST mRNA CTD PMID:25554681 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon analog affects the expression of FST mRNA CTD PMID:25554681 chloropicrin decreases expression ISO RGD:734008 6480464 chloropicrin results in decreased expression of FST mRNA CTD PMID:28476498 chloropicrin affects expression ISO RGD:734008 6480464 chloropicrin affects the expression of FST mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of FST mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of FST mRNA CTD PMID:37019170 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of FST mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:734008 6480464 Cisplatin results in increased expression of FST mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:2633 6480464 Cisplatin results in decreased expression of FST mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:734008 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FST mRNA, Cisplatin affects the reaction [Piroxicam results in decreased expression of FST mRNA] CTD PMID:21858171 , PMID:27392435 cobalt dichloride decreases expression ISO RGD:2633 6480464 cobaltous chloride results in decreased expression of FST mRNA CTD PMID:24386269 colforsin daropate hydrochloride multiple interactions ISO RGD:734008 6480464 FST protein inhibits the reaction [BMP6 protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]], FST protein inhibits the reaction [INHBA protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]] CTD PMID:18936084 copper atom multiple interactions ISO RGD:734008 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FST mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:2633 6480464 Copper results in increased expression of FST mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:734008 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FST mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:2633 6480464 Copper results in increased expression of FST mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:734008 6480464 Copper Sulfate results in decreased expression of FST mRNA CTD PMID:19549813 corn oil multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA CTD PMID:32186404 crocidolite asbestos decreases expression ISO RGD:734008 6480464 Asbestos, Crocidolite results in decreased expression of FST mRNA CTD PMID:24160326 , PMID:29523930 crocidolite asbestos increases expression ISO RGD:734008 6480464 Asbestos, Crocidolite results in increased expression of FST mRNA CTD PMID:18687144 more ... cycloheximide multiple interactions ISO RGD:734008 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FST mRNA] CTD PMID:11007951 cyclosporin A decreases expression ISO RGD:734008 6480464 Cyclosporine results in decreased expression of FST mRNA CTD PMID:25562108 , PMID:27989131 dexamethasone multiple interactions ISO RGD:2633 6480464 Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of FST mRNA] CTD PMID:21149847 dexamethasone multiple interactions ISO RGD:734008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FST mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FST mRNA CTD PMID:28628672 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FST mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions ISO RGD:734008 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FST protein] CTD PMID:26598702 dibenzo[a,l]pyrene decreases expression EXP 6480464 dibenzo(a, l)pyrene results in decreased expression of FST mRNA CTD PMID:25908611 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of FST mRNA CTD PMID:28962523 dicrotophos increases expression ISO RGD:734008 6480464 dicrotophos results in increased expression of FST mRNA CTD PMID:28302478 diethyl malate affects expression EXP 6480464 diethyl malate affects the expression of FST mRNA CTD PMID:24814887 diethylstilbestrol decreases expression ISO RGD:734008 6480464 Diethylstilbestrol results in decreased expression of FST mRNA CTD PMID:36621641 dioxygen decreases expression ISO RGD:734008 6480464 Oxygen deficiency results in decreased expression of FST mRNA CTD PMID:24236059 , PMID:26516004 dioxygen multiple interactions ISO RGD:2633 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FST mRNA CTD PMID:33729688 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FST mRNA CTD PMID:30529165 dioxygen multiple interactions ISO RGD:734008 6480464 Oxygen affects the reaction [AHR protein results in increased expression of FST mRNA] CTD PMID:27103661 diuron decreases expression ISO RGD:2633 6480464 Diuron results in decreased expression of FST mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:734008 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:734008 6480464 Doxorubicin results in decreased expression of FST mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:2633 6480464 Endosulfan results in decreased expression of FST mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:734008 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FST mRNA CTD PMID:27188386 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of FST mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:734008 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FST mRNA CTD PMID:29432896 fipronil decreases expression ISO RGD:2633 6480464 fipronil results in decreased expression of FST mRNA CTD PMID:34044035 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FST mRNA CTD PMID:28329830 formaldehyde increases expression ISO RGD:734008 6480464 Formaldehyde results in increased expression of FST mRNA CTD PMID:27664576 fulvestrant increases expression ISO RGD:734008 6480464 Fulvestrant results in increased expression of FST mRNA CTD PMID:16298037 , PMID:31646340 fulvestrant multiple interactions ISO RGD:734008 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of FST mRNA] more ... CTD PMID:31646340 furan increases expression EXP 6480464 furan results in increased expression of FST mRNA CTD PMID:24183702 furan increases expression ISO RGD:2633 6480464 furan results in increased expression of FST mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:734008 6480464 Genistein results in decreased expression of FST mRNA CTD PMID:26865667 gentamycin decreases expression ISO RGD:2633 6480464 Gentamicins results in decreased expression of FST mRNA CTD PMID:33387578 geraniol increases expression ISO RGD:734008 6480464 geraniol results in increased expression of FST mRNA CTD PMID:27683099 GW 4064 decreases expression EXP 6480464 GW 4064 results in decreased expression of FST mRNA CTD PMID:26655953 hydralazine multiple interactions ISO RGD:734008 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FST mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:734008 6480464 Hydrogen Peroxide results in increased expression of FST CTD PMID:18687144 indometacin multiple interactions ISO RGD:734008 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FST mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FST mRNA CTD PMID:28628672 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FST mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:734008 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FST mRNA CTD PMID:29432896 isoflavones decreases expression ISO RGD:734008 6480464 Isoflavones results in decreased expression of FST mRNA CTD PMID:16365062 leflunomide increases expression ISO RGD:734008 6480464 leflunomide results in increased expression of FST mRNA CTD PMID:28988120 lipopolysaccharide decreases expression ISO RGD:2633 329849007 LPS decreases expression of follistatin protein in rat cardiac fibroblasts RGD lipopolysaccharide increases expression ISO RGD:2633 6480464 Lipopolysaccharides results in increased expression of FST mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:2633 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of FST mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FST mRNA] CTD PMID:16415329 methamphetamine decreases expression ISO RGD:2633 6480464 Methamphetamine results in decreased expression of FST mRNA CTD PMID:28619521 Methandrostenolone decreases expression ISO RGD:2633 6480464 Methandrostenolone results in decreased expression of FST mRNA CTD PMID:21818626 methapyrilene increases expression ISO RGD:2633 6480464 Methapyrilene results in increased expression of FST mRNA CTD PMID:30467583 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of FST mRNA CTD PMID:18502557 methoxychlor decreases expression ISO RGD:2633 6480464 Methoxychlor results in decreased expression of FST mRNA CTD PMID:23303685 methoxychlor increases methylation ISO RGD:2633 6480464 Methoxychlor results in increased methylation of FST gene CTD PMID:23303685 methylisothiazolinone increases expression ISO RGD:734008 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FST mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:734008 6480464 methylmercuric chloride results in increased expression of FST mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:734008 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FST mRNA CTD PMID:27188386 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of FST mRNA CTD PMID:19162170 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:2633 6480464 Methylnitronitrosoguanidine results in increased expression of FST mRNA CTD PMID:15120970 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of FST mRNA CTD PMID:24535843 N-Nitrosopyrrolidine increases expression ISO RGD:734008 6480464 N-Nitrosopyrrolidine results in increased expression of FST mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO RGD:2633 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of FST mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FST mRNA] CTD PMID:16415329 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of FST mRNA CTD PMID:16100012 O-methyleugenol increases expression ISO RGD:734008 6480464 methyleugenol results in increased expression of FST mRNA CTD PMID:32234424 orphenadrine affects expression ISO RGD:2633 6480464 Orphenadrine affects the expression of FST mRNA CTD PMID:23665939 oxaliplatin increases expression ISO RGD:2633 6480464 oxaliplatin results in increased expression of FST mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:2633 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FST mRNA CTD PMID:25729387 oxybenzone increases expression ISO RGD:2633 6480464 oxybenzone results in increased expression of FST mRNA CTD PMID:30599193 ozone increases expression ISO RGD:734008 6480464 Ozone results in increased expression of FST mRNA CTD PMID:23033980 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FST mRNA CTD PMID:27106289 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of FST mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:2633 6480464 Acetaminophen results in decreased expression of FST mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:734008 6480464 Acetaminophen results in decreased expression of FST mRNA CTD PMID:21420995 paraquat increases expression ISO RGD:2633 6480464 Paraquat results in increased expression of FST mRNA CTD PMID:32680482 pentobarbital multiple interactions ISO RGD:2633 6480464 Pentobarbital inhibits the reaction [Estrogens results in increased expression of FST mRNA] CTD PMID:8612495 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FST mRNA CTD PMID:36331819 phenethyl isothiocyanate decreases expression ISO RGD:734008 6480464 phenethyl isothiocyanate results in decreased expression of FST mRNA CTD PMID:26678675 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FST mRNA], NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of FST mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:734008 6480464 Phenobarbital affects the expression of FST mRNA CTD PMID:19159669 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of FST mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:2633 6480464 Phenobarbital affects the expression of FST mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:734008 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FST mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:734008 6480464 Piroxicam results in decreased expression of FST mRNA CTD PMID:21858171 piroxicam multiple interactions ISO RGD:734008 6480464 Cisplatin affects the reaction [Piroxicam results in decreased expression of FST mRNA] CTD PMID:21858171 potassium iodide increases expression ISO RGD:2633 6480464 Potassium Iodide results in increased expression of FST protein CTD PMID:32593569 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of FST mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:734008 6480464 FST protein inhibits the reaction [BMP6 protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]], FST protein inhibits the reaction [INHBA protein inhibits the reaction [Colforsin results in increased secretion of Progesterone]] CTD PMID:18936084 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA CTD PMID:32186404 progesterone increases expression EXP 6480464 Progesterone results in increased expression of FST mRNA, Progesterone results in increased expression of FST mRNA alternative form CTD PMID:22238285 , PMID:22285243 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of FST mRNA CTD PMID:19363144 rac-lactic acid increases expression ISO RGD:734008 6480464 Lactic Acid results in increased expression of FST mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:734008 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of FST mRNA CTD PMID:19059307 raloxifene affects expression ISO RGD:734008 6480464 Raloxifene Hydrochloride affects the expression of FST mRNA CTD PMID:14699072 ranitidine multiple interactions ISO RGD:2633 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of FST mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of FST mRNA] CTD PMID:16415329 resveratrol increases expression ISO RGD:734008 6480464 resveratrol results in increased expression of FST mRNA CTD PMID:17257620 , PMID:25888808 SB 431542 multiple interactions ISO RGD:734008 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:734008 6480464 Asbestos, Serpentine results in decreased expression of FST mRNA CTD PMID:24160326 sevoflurane affects expression ISO RGD:2633 6480464 sevoflurane affects the expression of FST mRNA CTD PMID:15967596 silicon dioxide affects expression ISO RGD:734008 6480464 Silicon Dioxide analog affects the expression of FST mRNA CTD PMID:25895662 simvastatin multiple interactions EXP 6480464 FST protein inhibits the reaction [Simvastatin results in decreased phosphorylation of AKT1 protein] more ... CTD PMID:33034787 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of FST mRNA CTD PMID:16014739 sodium dichromate increases expression ISO RGD:2633 6480464 sodium bichromate results in increased expression of FST mRNA CTD PMID:22561333 sodium dodecyl sulfate decreases expression ISO RGD:734008 6480464 Sodium Dodecyl Sulfate results in decreased expression of FST mRNA CTD PMID:31734321 sunitinib decreases expression ISO RGD:734008 6480464 Sunitinib results in decreased expression of FST mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:734008 6480464 Tamoxifen affects the expression of FST mRNA CTD PMID:14699072 tamoxifen decreases expression ISO RGD:734008 6480464 Tamoxifen results in decreased expression of FST mRNA CTD PMID:16298037 tamoxifen multiple interactions ISO RGD:734008 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of FST mRNA CTD PMID:19059307 temozolomide increases expression ISO RGD:734008 6480464 Temozolomide results in increased expression of FST mRNA CTD PMID:31758290 testosterone increases expression EXP 6480464 Testosterone results in increased expression of FST mRNA, Testosterone results in increased expression of FST protein CTD PMID:22138414 testosterone decreases expression ISO RGD:734008 6480464 Testosterone results in decreased expression of FST mRNA CTD PMID:33359661 testosterone multiple interactions EXP 6480464 FST mutant form inhibits the reaction [Testosterone results in increased expression of MYH2 protein] CTD PMID:22138414 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FST mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide increases expression ISO RGD:2633 6480464 Thioacetamide results in increased expression of FST mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of FST mRNA CTD PMID:27760801 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FST mRNA CTD PMID:29950665 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FST mRNA CTD PMID:23409001 topotecan multiple interactions ISO RGD:2633 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FST mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:2633 6480464 Topotecan results in increased expression of FST mRNA CTD PMID:25729387 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of FST mRNA CTD PMID:19363144 trichostatin A decreases expression ISO RGD:734008 6480464 trichostatin A results in decreased expression of FST mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:734008 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FST mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:734008 6480464 Triclosan results in increased expression of FST mRNA CTD PMID:30510588 triptonide increases expression EXP 6480464 triptonide results in increased expression of FST mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of FST mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:734008 6480464 troglitazone results in increased expression of FST mRNA CTD PMID:19140230 urethane increases expression ISO RGD:734008 6480464 Urethane results in increased expression of FST mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:734008 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of FST mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:734008 6480464 Valproic Acid results in decreased expression of FST mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:734008 6480464 Valproic Acid affects the expression of FST mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:734008 6480464 Valproic Acid results in increased expression of FST mRNA CTD PMID:23179753 , PMID:34742744 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of FST mRNA CTD PMID:17292431 , PMID:17963808 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of FST mRNA CTD PMID:18930951 vitamin E increases expression ISO RGD:734008 6480464 Vitamin E results in increased expression of FST mRNA CTD PMID:19244175
